Prospective Multicentre Randomized Double-Blind Placebo-Controlled Parallel Group Study on the Efficacy and Tolerability of StroVac® in Patients With Recurrent Symptomatic Bacterial Urinary Tract Infections
100 Clinical Results associated with Strathmann GmbH & Co. KG
Login to view more data
0 Patents (Medical) associated with Strathmann GmbH & Co. KG
Login to view more data
1
Literatures (Medical) associated with Strathmann GmbH & Co. KG
International urology and nephrology
Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
Author: Nestler, S ; Neisius, A ; Horstmann, A H ; Fabry, W ; Peschel, C ; Vahlensieck, W
100 Deals associated with Strathmann GmbH & Co. KG
Login to view more data
100 Translational Medicine associated with Strathmann GmbH & Co. KG
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!